Hot Features
AFT Pharmaceuticals Limited, together with its subsidiaries, develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally. The company offers proprietary and in-licensed products, including patented, branded, and generic drugs; and products for use ... AFT Pharmaceuticals Limited, together with its subsidiaries, develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally. The company offers proprietary and in-licensed products, including patented, branded, and generic drugs; and products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, natural health, pain management, skin care, sleeping aids, supplements, and other products. It has a research and development collaboration with Hyloris Pharmaceuticals SA for the development of the Maxigesic IV product. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.06 | 1.88087774295 | 3.19 | 3.3 | 3.19 | 5359 | 3.23715232 | DE |
| 4 | 0.11 | 3.50318471338 | 3.14 | 3.3 | 2.73 | 4772 | 3.05709917 | DE |
| 12 | 0.25 | 8.33333333333 | 3 | 3.3 | 2.73 | 3342 | 3.00027434 | DE |
| 26 | 0.06 | 1.88087774295 | 3.19 | 3.37 | 2.73 | 2224 | 3.03848425 | DE |
| 52 | 0.65 | 25 | 2.6 | 3.37 | 2.2 | 2450 | 2.78840108 | DE |
| 156 | -0.4 | -10.9589041096 | 3.65 | 3.65 | 2.15 | 2212 | 2.76529846 | DE |
| 260 | -1.06 | -24.5939675174 | 4.31 | 4.8 | 2.15 | 2827 | 3.18963001 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.